Energy & environment · 18/01/2007Updated: 10/17/2026 · 1 min read
West Pharmaceutical Service to Release Byproduct Materials Facility in Lionville, PA
Summary
The U.S. Nuclear Regulatory Commission (NRC) has made the Environmental Assessment and Finding of No Significant Impact for License Amendment to Byproduct Materials License No. 37-30229-01 publicly available, allowing West Pharmaceutical Service to terminate its license and release its facility in Lionville, PA.
Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →